A Phase III Trial to Compare ETC vs, EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN).
Phase of Trial: Phase III
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Ibandronic acid (Primary) ; Capecitabine; Cyclophosphamide; Epirubicin; Paclitaxel
- Indications Early breast cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms GAIN
- 12 Dec 2015 Results of retrospective analysis presented at the 38th Annual San Antonio Breast Cancer Symposium.
- 16 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2013 Primary endpoint 'Disease-free-survival' has not been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History